Loading…

A Comparison of 11 C-Labeled l -DOPA and l -Fluorodopa as Positron Emission Tomography Tracers for the Presynaptic Dopaminergic System

11 C-labeled 3,4-Dihydroxy-phenyl-l-alanine (L-DOPA) and l-fluorodopa were used as tracers for the functional state of the presynaptic dopamine system in anesthetized monkeys with positron emission tomography, The radiotracer disposition in brain tissue and plasma were studied and effects induced by...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cerebral blood flow and metabolism 1999-10, Vol.19 (10), p.1142-1149
Main Authors: Torstenson, Richard, Tedroff, Joakim, Hartvig, Per, Fasth, Karl-Johan, Lågström, Bengt
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:11 C-labeled 3,4-Dihydroxy-phenyl-l-alanine (L-DOPA) and l-fluorodopa were used as tracers for the functional state of the presynaptic dopamine system in anesthetized monkeys with positron emission tomography, The radiotracer disposition in brain tissue and plasma were studied and effects induced by pharmacologic challenges were evaluated, 6 R-l-erythro-5,6,7,8-tetrahydrobiopterin (6 R-BH 4 ) increased the striatal influx rate constant, e.g., striatal K i for l-[β- 11 C]DOPA, but it induced no effect on the K i -value using l-[β- 11 C]-6-fluorodopa. Studies of radiolabeled tracer and metabolites in plasma showed substantial differences between the two tracers. At baseline conditions, 60% unchanged l-[β- 11 C]DOPA was detected in plasma 50 minutes after tracer injection and the 3- O-methylated fraction accounted for 25% of total radioactivity. For l-[β- 11 C]-6-fluorodopa, the relation was inverse; about 25% unchanged tracer and 60% 3- O-methyl metabolite were present in plasma after 50 minutes. A site-specific 11 C-labeling in the carboxylic position in the molecules revealed a significant specific retention of radioactivity in striatum with l-[carboxy- 11 C]-6-fluorodopa but not with l-[carboxy- 11 C]DOPA. The 3- O-methyl metabolite of l-DOPA is known to pass the blood-brain barrier and may interfere with the calculation of the K i value using a brain reference region. Thus, extensive 3- O-methylation in circulation of the fluorinated analog could obscure the detectability of potential functional change in striatal K i of the tracer when using a reference tissue model for calculation.
ISSN:0271-678X
1559-7016
DOI:10.1097/00004647-199910000-00011